IGF-2 receptor modulators (EpiCept)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameIGF-2 receptor modulators (EpiCept)
Drug Alias NameIGF modulator (Maxim)IGF-2 receptor modulators (Maxim)insulin-like growth factor modulator (Maxim)MX-116839MX-128504 +[10] 
ClassificationSmall molecules
Mechanisms of ActionInsulin-like growth factor II receptor modulatorsApoptosis stimulants
TargetsInsulin-like growth factor II receptor
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMaxim Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEpicept CorpMaxim Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A